(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.


Figure 1


Fig. 1. Phosphorylation of tropomyosin-1 downstream of ERK and its inhibition by ML-7. (A) Exponentially growing COS cells, HEK293 cells and HUVECs were extracted and processed for immunodetection of tropomyosin and actin using specific antibodies. (B) Exponentially growing HEK293 cells were transfected with a plasmid expressing wild-type (wt) tropomyosin-1. The next day, cells were incubated in phosphate-free culture medium in the presence of H3[32P]O4 for 90 minutes. Cells were pre-treated for 60 minutes with vehicle (DMSO 0.25%), PD098059 (50 µM; P) or UO0126 (50 µM; U), and treated or not with H2O2 for 30 minutes (250 µM) in the presence of the phosphatase inhibitor NaF (1 mM). The proteins were extracted and were subject to immunoprecipitation with a monoclonal antibody against tropomyosin (TM). Immunoprecipitated proteins were separated by SDS-PAGE. Dried gels were analyzed with PhosphorImager. Lower panel: extracts were made before and after transfection and were processed for immunodetection of tropomyosin. P-TM, phospho-tropomyosin. (C) HUVECs plated in a gelatin-coated Petri dish were electroporated with a plasmid expressing FLAG-tagged tropomyosin-1. The next day, cells were pre-treated or not with PD098059 (50 µM for 60 minutes), UO0126 (50 µM for 60 minutes), treated or not with H2O2 (250 µM for 30 minutes) and afterwards were extracted in IEF buffer. Proteins were separated by 2D electrophoresis (pH 4.5-5.5), transferred onto a nitrocellulose membrane and subject to immunodetection using a monoclonal against the FLAG epitope. (D) HUVECs plated in gelatin-coated Petri dishes were electroporated with a plasmid expressing HA-tagged tropomyosin-1. The next day, cells were pre-treated or not with ML-7 (25 µM for 60 minutes), treated or not with H2O2 (250 µM for 30 minutes) and were processed as in C, except that immunodetection was performed using a monoclonal antibody against HA.